Embolex and Ranitidine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Embolex (dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride) and Ranitidine (ranitidine). Common drug interactions include lordosis among females and disease progression among males.

The phase IV clinical study analyzes what interactions people have when they take Embolex and Ranitidine. It is created by eHealthMe based on reports of 40 people who take the same drugs from the FDA, and is updated regularly.

What is Embolex?

Embolex has active ingredients of dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride. eHealthMe is studying from 1,161 Embolex users. Check the latest studies of Embolex.

What is Ranitidine?

Ranitidine has active ingredients of ranitidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 234,475 Ranitidine users. Check the latest studies of Ranitidine.

On Jul, 11, 2026

40 people who take Embolex and Ranitidine together, and have interactions are studied.

Embolex and Ranitidine drug interactions.

What are the common drug interactions of Embolex and Ranitidine, by gender? *:

female:

Lordosis (outward curve of the back bone)
Malaise (a feeling of general discomfort or uneasiness)
Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
Muscle tightness
Myofascial pain syndrome (a painful condition that affects the muscles and the sheath of the tissue)
Nocturia (the need to get up in the night to urinate)
Osteopenia (a condition where bone mineral density is lower than normal)
Osteoporosis postmenopausal (weak bone with possibility to break after stopped menstrual cycles)
Pain
Nausea (feeling of having an urge to vomit)

male:

Disease progression
Dyspnoea (difficult or laboured respiration)
C-reactive protein increased
Drug ineffective
Gamma-glutamyltransferase increased
Hepatitis b surface antigen positive
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
General physical health deterioration (weak health status)
Hepatitis b
Anti-hbc antibody positive

What are the common drug interactions of Embolex and Ranitidine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Seizure (abnormal excessive or synchronous neuronal activity in the brain)

30-39:

Bradycardia (abnormally slow heart action)
Cerebral haemorrhage (bleeding within the brain)
Hypertension (high blood pressure)
Nausea (feeling of having an urge to vomit)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Vomiting
Acute disseminated encephalomyelitis (acute intense attack of inflammation (swelling) in the brain and spinal cord)
Blood disorder
Brain death
Cerebral hypoperfusion (a condition in which the brain doesn't get enough blood)

40-49:

C-reactive protein increased
Csf neutrophil count increased
Diarrhoea
Dysphagia (a condition in which swallowing is difficult or painful)
Dysphonia (speech disorder attributable to a disorder of phonation)
Dyspnoea (difficult or laboured respiration)
Ear discomfort
Gait disturbance
Hypotension (abnormally low blood pressure)
Meningism (the triad of nuchal rigidity (neck stiffness), photophobia (intolerance of bright light) and headache. it is a sign of irritation of the meninges)

50-59:

Decubitus ulcer (a chronic ulcer of the skin caused by prolonged pressure on it)
Hepatitis b
Anti-hbc antibody positive
Anaphylactoid reaction (type of anaphylaxis that does not involve an allergic reaction but is due to direct mast cell degranulation)
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Blood urea increased
Conjunctivitis (pink eye)
Drug ineffective
Entropion (eyelid (usually the lower lid) folds inward)
Epidermal necrolysis (skin condition that is usually caused by a reaction to drugs)

60+:

Dyspnoea (difficult or laboured respiration)
Jugular vein thrombosis (clot in jugular vein)
Abdominal pain
Alanine aminotransferase increased
Aspartate aminotransferase increased
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Blood bilirubin increased
Blood creatinine increased
Body temperature increased
Brain hypoxia (reduced supply of oxygen to the brain)

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 21 people, 52.50%
Urinary Tract Infection: 9 people, 22.50%
Venous Thrombosis (blood clot (thrombus) that forms within a vein): 8 people, 20.00%
Colon Cancer: 8 people, 20.00%
Rickets (softening of bones): 8 people, 20.00%
Urge Incontinence (urinary incontinence): 7 people, 17.50%
Birth Control: 7 people, 17.50%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 6 people, 15.00%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 12.50%
Pain: 5 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Embolex and Ranitidine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously